Trial intelligence / Profile preview

Dexmedetomidine for ICU patient sedation during intrahospital transport for diagnostic testing

ChiCTR-TRC-12002743Phase 4Completed

Sponsor
The 2nd Affiliated Hospital of Harbin Medical University
Start
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in critical illness (2 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoint: Adverse events during intrahospital transport to diagnostic tests. Started Dec 2012; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

critical illness

Beyond the preview

Go deeper on ChiCTR-TRC-12002743.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002743.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call